Cargando…
Broadly neutralizing antibody responses in the longitudinal primary HIV-1 infection Short Pulse Anti-Retroviral Therapy at Seroconversion cohort
Development of immunogens that elicit an anti-HIV-1 broadly neutralizing antibody (bnAb) response will be a key step in the development of an effective HIV-1 vaccine. Although HIV-1 bnAb epitopes have been identified and mechanisms of action studied, current HIV-1 envelope-based immunogens do not el...
Autores principales: | Granger, Luke A., Huettner, Isabella, Debeljak, Franka, Kaleebu, Pontiano, Schechter, Mauro, Tambussi, Giuseppe, Weber, Jonathan, Miro, Jose M., Phillips, Rodney, Babiker, Abdel, Cooper, David A., Fisher, Martin, Ramjee, Gita, Fidler, Sarah, Frater, John, Fox, Julie, Doores, Katie J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8505148/ https://www.ncbi.nlm.nih.gov/pubmed/34127581 http://dx.doi.org/10.1097/QAD.0000000000002988 |
Ejemplares similares
-
Duration of HIV-1 Viral Suppression on Cessation of Antiretroviral Therapy in Primary Infection Correlates with Time on Therapy
por: Stöhr, Wolfgang, et al.
Publicado: (2013) -
Enhanced normalisation of CD4/CD8 ratio with early antiretroviral therapy in primary HIV infection
por: Thornhill, John, et al.
Publicado: (2014) -
Brief Report: Enhanced Normalization of CD4/CD8 Ratio With Earlier Antiretroviral Therapy at Primary HIV Infection
por: Thornhill, John, et al.
Publicado: (2016) -
Mean Corpuscular Volume as a Marker for Adherence to Zidovudine-Containing Therapy in HIV-Infected Adults
por: Mugisha, Joseph O, et al.
Publicado: (2012) -
Biological impact of recurrent sexually transmitted infections on HIV seroconversion among women in South Africa: results from frailty models
por: Wand, Handan, et al.
Publicado: (2015)